Adherence to inhaled medication adherence is critical for reducing the risk of acute exacerbations, controlling disease progression, improving quality of life and lowering healthcare costs in patients with chronic obstructive pulmonary disease (COPD). However, significant variability in adherence exists among patients. This study aimed to identify distinct patterns of inhaled medication adherence and their influencing factors using latent class analysis.
Methods:
A total of 621 inpatients with COPD (85.3% men) hospitalised at a tertiary hospital between September and December 2023 were enrolled. Inhaled medication adherence was evaluated using the Chinese version of the Test of Adherence to Inhalers (TAI). Medication knowledge and beliefs were measured using a self-administered questionnaire. Latent class analysis based on TAI scores, along with multinomial logistic regression, was used to explore factors influencing inhalation medication adherence.
Results:
Three adherence classes were identified: poor adherence (13.9%), moderate adherence (28.8%) and good adherence (57.3%). Significant differences among these groups were found in treatment payment methods, income sources, duration of inhaled drug use, frequency of drug usage, number of disease-related hospital visits in the past 2 years, self-care ability and scores on the medication knowledge and belief questionnaires.
Conclusions:
Distinct adherence patterns exist among patients with COPD, influenced by socioeconomic and behavioural factors. These findings highlight the need for targeted intervention programmes based on adherence profiles to improve inhaled medication adherence in patients with COPD.
LozanoRNaghaviMForemanK, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi:10.1016/s0140-6736(12)61728-0
3.
LiNWangNLinSYuanYHuangFZhuP.A latent profile analysis of rest-activity behavior patterns among community-dwelling older adults and its relationship with intrinsic capacity. Sci Rep. 2024;14(1):18786. doi:10.1038/s41598-024-69114-y
4.
YinPWuJWangL, et al. The burden of COPD in China and its provinces: findings from the Global Burden of Disease Study 2019. Front Public Health. 2022;10:859499. doi:10.3389/fpubh.2022.859499
5.
ZengYCaiSChenY, et al. Current status of the treatment of COPD in China: a multicenter prospective observational study. Int J Chron Obstruct Pulmon Dis. 2020;15:3227-3237. doi:10.2147/copd.S274024
6.
KimJALimMKKimKParkJRheeCK.Adherence to inhaled medications and its effect on healthcare utilization and costs among high-grade chronic obstructive pulmonary disease patients. Clin Drug Investig. 2018;38(4):333-340. doi:10.1007/s40261-017-0612-2
7.
López-CamposJLQuintana GallegoECarrasco HernándezL.Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503-1515. doi:10.2147/copd.S170848
8.
LiuLXiaoJYuS.A survey and analysis of inhalation medication adherence among 977 COPD patients in a region of northern China. Eur J Med Res. 2025;30(1):258. doi:10.1186/s40001-025-02535-1
9.
WuJMengWMaY, et al. Errors and adherence to inhaled medications in Chinese adults with COPD. J Gen Intern Med. 2024;39(1):69-76. doi:10.1007/s11606-023-08378-y
10.
HumenbergerMHornerALabekA, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-3
11.
AmirsalariSYousefiJRadfarS, et al. Cochlear implant outcomes in children with motor developmental delay. Int J Pediatr Otorhinolaryngol. 2012;76(1):100-103. doi:10.1016/j.ijporl.2011.10.011
12.
WurstKESt LaurentSMullerovaHDavisKJ.Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2014;9:1021-1031. doi: 10.2147/COPD.S58258
13.
BlackstockFCWebsterKEMcDonaldCFHillCJ.Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: a randomized controlled trial. Respirology. 2014;19(2):193-202. doi:10.1111/resp.12203
14.
SpruitMASinghSJGarveyC, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-e64. doi:10.1164/rccm.201309-1634ST
15.
MonteiroCMaricotoTPrazeresFAugusto SimõesPAugusto SimõesJ.Determining factors associated with inhaled therapy adherence on asthma and COPD: a systematic review and meta-analysis of the global literature. Respir Med. 2022;191:106724. doi:10.1016/j.rmed.2021.106724
16.
MengWWCuiYNLuoLJ, et al. [Reliability and validity of the Chinese version of the test of the adherence to inhalers (TAI)]. Zhonghua Jie He He Hu Xi Za Zhi. 2022;45(5):423-430. doi:10.3760/cma.j.cn112147-20211108-00783
17.
MengJ.Effect of Motivational Interview on Improving Medication Compliance of Patients with Chronic Heart Failure [master’s thesis]. Peking Union Medical College; 2011.
18.
MaXQResearch on the Prevalence of Chronic Diseases and Medication Use Among Elderly Patients in China [dissertation]. Henan University; 2015.
19.
GregorianoCDieterleTBreitensteinAL, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237. doi:10.1186/s12931-018-0936-3
20.
HomętowskaHŚwiątoniowska-LoncNKlekowskiJChabowskiMJankowska-PolańskaB.Treatment adherence in patients with obstructive pulmonary diseases. Int J Environ Res Public Health. 2022;19(18):11573. doi:10.3390/ijerph191811573
21.
WangCXuJYangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706-1717. doi:10.1016/s0140-6736(18)30841-9
22.
O’TooleJKrishnanMRiekertKEakinMN.Understanding barriers to and strategies for medication adherence in COPD: a qualitative study. BMC Pulm Med. 2022;22(1):98. doi:10.1186/s12890-022-01892-5
23.
KaleMSFedermanADKrauskopfK, et al. The association of health literacy with illness and medication beliefs among patients with chronic obstructive pulmonary disease. PLoS One. 2015;10(4):e0123937. doi:10.1371/journal.pone.0123937
24.
HorneRWeinmanJBarberNElliottRMorganM.Concordance, adherence and compliance in medicine taking. National Co-Ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO);2005.
25.
OcakliBOzmenITunçayEA, et al. A comparative analysis of errors in inhaler technique among COPD versus asthma patients. Int J Chron Obstruct Pulmon Dis. 2018;13:2941-2947. doi:10.2147/copd.S178951
26.
AbdulredhaMHAljobouriHJAlareedhMD.Evaluation of inhaler technique in COPD and asthma patients. Kufa Med J. 2023;19(1):12014. doi:10.36330/kmj.v19i1.12014
27.
PetiteSEHessMWWachtelH.The role of the pharmacist in inhaler selection and education in chronic obstructive pulmonary disease. J Pharm Technol. 2021;37(2):95-106. doi:10.1177/8755122520937649
28.
MahlerDA.The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease. Respir Med. 2020;161:105857. doi:10.1016/j.rmed.2019.105857
29.
PolettiVPagniniFBanfiPVolpatoE.Illness perceptions, cognitions, and beliefs on COPD patients’ adherence to treatment – a systematic review. Patient Prefer Adherence. 2023;17:1845-1866. doi:10.2147/ppa.S412136
30.
Bosnic-AnticevichSBenderBGShulerMTHessMKocksJWH. Recognizing and tackling inhaler technique decay in asthma and chronic obstructive pulmonary disesase (COPD) clinical practice. J Allergy Clin Immunol Pract. 2023;11(8):2355-2364.e5. doi:10.1016/j.jaip.2023.04.031
31.
SalvadoSGriloEHenriquesHFerrazIGasparFBaixinhoC.Pulmonary rehabilitation nursing interventions promoting self-care in elderly people with chronic obstructive pulmonary disease (at home). Healthcare (Basel). 2025;13(17):2176. doi:10.3390/healthcare13172176
32.
NgoCQPhanDMVuGV, et al. Inhaler technique and adherence to inhaled medications among patients with acute exacerbation of chronic obstructive pulmonary disease in Vietnam. Int J Environ Res Public Health. 2019;16(2):185. doi:10.3390/ijerph16020185
33.
RoglianiPOraJPuxedduEMateraMGCazzolaM.Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117-123. doi:10.1016/j.rmed.2017.06.007
34.
PolańskiJChabowskiMŚwiątoniowska-LoncNMazurGJankowska-PolańskaB.Medication compliance in COPD patients. Adv Exp Med Biol. 2020;1279:81-91. doi:10.1007/5584_2020_508
35.
HooZHWildmanMJCampbellMJWaltersSJGardnerB.A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis. Patient Prefer Adherence. 2019;13:283-294. doi:10.2147/ppa.S186417
36.
CalapaiMPuzzoLBovaG, et al. Effects of physical exercise and motor activity on depression and anxiety in post-mastectomy pain syndrome. Life (Basel). 2024;14(1):77. doi:10.3390/life14010077
37.
Calderón-GarcidueñasLTorres-SolorioAKKuleszaRJ, et al. Gait and balance disturbances are common in young urbanites and associated with cognitive impairment. Air pollution and the historical development of Alzheimer’s disease in the young. Environ Res. 2020;191:110087. doi:10.1016/j.envres.2020.110087
38.
JansenEMvan de HeiSJDierickBJHKerstjensHAMKocksJWHvan BovenJFM. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J Thorac Dis. 2021;13(6):3846-3864. doi:10.21037/jtd-20-2360
39.
CaoXChenCZhangJ, et al. Aging metrics incorporating cognitive and physical function capture mortality risk: results from two prospective cohort studies. BMC Geriatr. 2022;22(1):378. doi:10.1186/s12877-022-02913-y
40.
Turégano-YedroMTrillo-CalvoENavarroIRF, et al. Inhaler adherence in COPD: a crucial step towards the correct treatment. Int J Chron Obstruct Pulmon Dis. 2023;18:2887-2893. doi:10.2147/copd.S431829
41.
AlotaibiSDAl GhamdiFA.The role of health education among nurses in promoting medication adherence: strategies and outcomes. J Healthc Sci. 2024;4(12):1024-1030. doi:10.52533/JOHS.2024.41251
42.
BogartMStanfordRHLalibertéFGermainGWuJWDuhMS.Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343-352. doi:10.2147/copd.S184653
43.
UsmaniOSHickeyAJGuranliogluD, et al. The impact of inhaler device regimen in patients with asthma or COPD. J Allergy Clin Immunol Pract. 2021;9(8):3033-3040.e1. doi:10.1016/j.jaip.2021.04.024
44.
ManninoDBogartMWuB, et al. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: a real-world study. Respir Med. 2022;197:106807. doi:10.1016/j.rmed.2022.106807
